IP Library Granted Patent US 12,077,582
Granted Patent B2
US 12,077,582 · App. 17/946,921 · Granted Sep 3, 2024

Antibodies to L-type voltage gated channels and related methods

Inventors: Wilfred Arthur Jefferies (Surrey, CA); Kyung Bok Choi (Surrey, CA); Shawna Rose Stanwood (Burnaby, CA); Franz Fenninger (Vancouver, CA); Brett Alexander Eyford (Vancouver, CA); Lonna Munro (Vancouver, CA); Cheryl Gurine Pfeifer (Vancouver, CA); Reinhard Gabathuler (Quebec, CA)
Assignee: The University of British Columbia
C07K16/28C07K14/705C07K16/30C07K2317/33C07K2317/34C07K2317/56C07K2317/565C07K2317/73C07K2317/76
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,077,582
App. No.
17/946,921
Granted
Sep 3, 2024
Kind
B2
Abstract

Provided are antibodies, and antigen-binding fragments thereof, which specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage gated calcium channel, and related compositions, kits, and methods of use thereof, for instance, administration to a subject in need thereof to modify an immune response, for example, in the treatment of cancer.

Claims (2)

1. An isolated antibody, or antigen-binding fragment thereof, which binds to an alpha I subunit of an L-type voltage-gated calcium channel, wherein the antibody or antigen-binding fragment thereof, specifically binds to an amino acid sequence of an extracellular domain selected from SEQ ID NO:2 and which comprises:

a heavy chain variable region (V H ) having the V H sequence of SEQ ID NO:37; and a light chain variable region (V L ) having the V L sequence of SEQ ID NO:41, wherein (i) V H comprises V H CDR1 and V H CDR2 amino acid sequences of SEQ ID NOS:38-39; and (ii) V L comprises V L CDR1, V L CDR2 and V L CDR3 amino acid sequences of SEQ ID NO: 42, LAS, and SEQ ID NO: 44.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2022
From: PASCAL BIOSCIENCES INC.
To: THE UNIVERSITY OF BRITISH COLUMBIA
Reel/Frame 061478/0843 →
CHANGE OF NAME Recorded Sep 19, 2022
From: BIOMMUNE TECHNOLOGIES INC.
To: PASCAL BIOSCIENCES INC.
Reel/Frame 061469/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2022
From: JEFFERIES, WILFRED; GABATHULER, REINHARD; STANWOOD, SHAWNA; CHOI, KYUNG BOK; FENNINGER, FRANZ; EYFORD, BRETT ALEXANDER; MUNRO, LONNA; PFEIFER, CHERYL GURINE
To: BIOMMUNE TECHNOLOGIES INC.
Reel/Frame 061126/0315 →
Continuity (5)
Continuation 16751951 · Jan 24, 2020
Continuation 15549912
Provisional Application 62280557 · Jan 19, 2016
Provisional Application 62115823 · Feb 13, 2015
Related Publication 20230203154A1 · Jun 29, 2023